Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes

Diabetologia(2024)10.1007/s00125-024-06339-6Source: DataRank Database

Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes is a research paper published in Diabetologia (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 7.07)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Erin M. Tallon ORCID,Matthew E. Brown ORCID,Amanda L. Posgai ORCID,Mark A. Clements ORCID,Todd M. Brusko ORCID

Live enrichment

PubMed:39694914 PMC:PMC11832708 OpenAlex:https://openalex.org/W4405530298

National Institute of Allergy and Infectious Diseases

Grant: P01 AI042288

Leona M. and Harry B. Helmsley Charitable Trust

Grant: 2019PG-T1D011

JDRF

Grant: 3-PDF-2022-1137-A-N

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: K99 DK140511

National Institutes of Health

Grant: 5P01AI042288-17

Administrative Core

National Institutes of Health

Grant: 1K99DK140511-01

Fcy Receptor-Mediated Pharmacogenomics of Antibody Therapies in Type 1 Diabetes

Emilie Rosebud Diabetes Research Foundation

Orlando Brown, Jr.

FWCI

7.07

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00125-024-06339-6.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00125-024-06339-6.pdf

publisherhttps://link.springer.com/article/10.1007/s00125-024-06339-6/fulltext.html

journalhttps://doi.org/10.1007/s00125-024-06339-6

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39694914

Fields of Study

Diabetes and associated disordersPancreatic function and diabetesBiomedical and Engineering Education0301 basic medicine0303 health sciences03 medical and health sciencesHumansDiabetes Mellitus, Type 1Machine LearningArtificial IntelligenceDrug DiscoveryAnimalsHypoglycemic Agents

MeSH Terms

Machine LearningAnimalsArtificial IntelligenceDiabetes Mellitus, Type 1HumansHypoglycemic AgentsDrug Discovery

Keywords

RepurposingClinical trialInterpretabilityArtificial intelligenceMachine learningDiseaseComputer scienceMedicineDrug discoveryBioinformaticsBiologyReviewImmunotherapyDrug responsetype 1 diabetesPharmacogeneticsDrug RepurposingPrecision MedicineDigital TwinDiabetes Mellitus, Type 1HumansAnimalsHypoglycemic Agents